Ethical Issues of Gene Therapy

The world trade market for cell and gene based therapies is expected to greater than the $20 billion USD mark by 2025, with an annual growth rate of 21%. The main targets for cell based therapies are high impact disease areas with significant incurable needs, including cancer, heart disease, neurodegenerative diseases, musculoskeletal disorders and autoimmune diseases gene therapies should then not be rushed to market but companies should gather the required data about the impact of therapy in human community with the appropriate duration of follow-up to allow proper evaluation by payers.

 

    Ethical Issues of Gene Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in